HHC
CHE icon

Hutchin Hill Capital’s Chemed CHE Stock Holding History

Hutchin Hill Capital’s Portfolio CHE Stock Details CHE Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2014
Q1 		– Sell
-21,500
Closed -$1.65M – 618
2013
Q4 		$1.65M Buy
21,500
+10,800
+101% +$796K 0.11% 185
2013
Q3 		$765K Buy
+10,700
New +$761K 0.07% 225

Other funds holding CHE

Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
RP
Riverbridge Partners Minneapolis, Minnesota $3.58B AUM 4.02% 1-Year Est. Return
RA
Royce & Associates New York $12.4B AUM 64.17% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BFA
BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return
VVP
Vulcan Value Partners Birmingham, Alabama $3.29B AUM 6.08% 1-Year Est. Return
Schroder Investment Management Group
Schroder Investment Management Group London, United Kingdom $141B AUM 34.18% 1-Year Est. Return
GI
GAMCO Investors Greenwich, Connecticut $11.1B AUM 41.79% 1-Year Est. Return
VBA
Van Berkom & Associates Montreal, Quebec, Canada $3.1B AUM 12.88% 1-Year Est. Return

Hutchin Hill Capital's CHE Position: Q1 2014 in Review

Hutchin Hill Capital sold out of Chemed (CHE) in Q1 2014, closing a stake of 21,500 shares — an estimated $1.65M sold.

Hutchin Hill Capital first reported a position in CHE in Q3 2013 and held it in 2 quarters. The position peaked at $1.65M in Q4 2013. 194 funds tracked by Wall St. Rank hold CHE as of Q1 2014.

  • Hutchin Hill Capital reported no remaining Chemed position as of Q1 2014 after selling out during the quarter.
  • Hutchin Hill Capital sold 21,500 Chemed shares in Q1 2014, an estimated $1.65M.
  • Hutchin Hill Capital first reported a position in Chemed in Q3 2013 and held it in 2 quarters.
  • Hutchin Hill Capital's Chemed position peaked at $1.65M in Q4 2013.
  • 194 funds tracked by Wall St. Rank held Chemed as of Q1 2014.

Based on Hutchin Hill Capital's 13F filing for Q1 2014, filed 15 May 2014.